INSURANCE – Amends existing law to revise provisions regarding 340B drug pricing program reporting.
Summary
S1390 amends Idaho law governing reporting by 340B safety net entities under the federal 340B drug pricing program. The bill is described as a technical cleanup measure that streamlines existing reporting requirements by changing the reporting period from a calendar year to a fiscal year, removing data elements that are not required by the federal program, and clarifying the financial information that must be reported.
The stated goal is to make compliance easier for hospitals and other covered entities, reducing the need for additional software or technology investments while still ensuring that the reported information accurately reflects financial data. The bill does not change the federal 340B program itself; instead, it adjusts state-level reporting rules tied to that program.
Impact
The bill would revise Idaho’s statutory reporting requirements for 340B entities, including hospitals, by simplifying the data collection and submission process and aligning reporting more closely with fiscal-year accounting. Because the 340B program is federal and the bill is framed as a reporting-only change, the fiscal note states there is no expected revenue impact and no additional state or local government expenditure. Its practical effect is to reduce administrative burden on covered providers while preserving state oversight of 340B-related financial reporting.
Sentiment
The overall sentiment appears supportive and noncontroversial. The bill is presented as a technical fix and modernization of reporting rules, with proponents emphasizing simplification, accuracy, and reduced compliance costs. No committee transcript or recorded votes were provided, and the available materials do not show organized opposition.
Contention
No major points of contention are identified in the provided record. The only likely policy tension is between reducing reporting burdens for hospitals and safety net providers and maintaining the state’s ability to collect meaningful financial information about 340B participation. The bill’s sponsors characterize the changes as limited and administrative rather than substantive, suggesting little disagreement over the underlying policy.